Abstract
The constant presence of microcrystalline monosodium urate monohydrate (MSU) in joint fluid from acute gout was first documented in 1961 (McCarty and Hollander, 1961). MSU needles can be seen by ordinary light microscopy, but the strongly negative birefringence with axial extinction by compensated polarized light microscopy is a much more sensitive test that is quite specific. Van Leeuwenhoek (b. 1633) was the first to describe urate crystals, having obtained them from a draining tophus (McCarty, 1970a). He was unaware of their chemical composition, as uric (lithic) acid was not discovered until a century later (Scheele, 1776). It is of historic interest that A. B. Garrod had used polarized light microscopic inspection of fresh tissue sections cut by hand with a razor blade to identify urate crystals (Garrod, 1876). He wrote that “... in the constancy of such deposition lies the clue that has long been wanting; the occurrence of the deposit is at once pathognomonic and separates gout from every other disease which at first sight may appear allied to it.” Phagocytosis of MSU crystals by both polymorphonuclear and mononuclear cells was first described in recently erupted human skin tophi by the Viennese dermatologist Gustav Riehl (Riehl, 1897), a phenomenon re-discovered later in gouty joint fluid (McCarty, 1962).
From the Rheumatology Section, Department of Medicine, Medical College of Wisconsin, 8700 West Wisconsin Avenue, Milwaukee, Wisconsin 53226. Supported in part by grants AM 13069 and AM 05621.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Agudelo, C.A., Schumacher, H.R., Phelps, P.: Effect of exercise on urate crystal-induced inflammation in canine joints. Arthr. Rheum. 15, 609–616 (1972)
Allison, A.C., Harington, J.S., Birbeck, M.: An examination of the cytotoxic effects of silica on macrophages. J. exp. Med. 124, 141–153 (1966)
Andrews, R., Phelps, P.: Release of lysosomal enzymes from polymorphonuclear leukocytes (PMN) after phagocytosis of monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD) crystals: effect of colchicine and indomethacin. Arthr. Rheum. 14, 368 (abs.) (1971)
Bluhm, G.B., Riddle, J.M., Barnhart, L.: Intracellular formation of urate crystals. Arthr. Rheum. 12, 283 (abs.) (1969)
Borisy, G.G., Taylor, E.W.: The mechanism of action of colchicine binding of colchicine-3H to cellular protein. J. Cell Biol. 34, 525–533 (1967)
Brill, J.M., McCarty, D.J.: (Studies on the nature of gouty tophi. Freudweiler, M. Dtsch. Arch. klin. Med. 1899) An abridged translation with comments. Ann. intern. Med. 60, 486–505 (1964)
Brill, J.M., McCarty, D.J.: (Experimental investigations into the origin of gouty tophi. Freudweiler,M. Dtsch. Arch. klin. Med. 1901) An abridged translation with comments. Arthr. Rheum. 8, 267–288 (1965)
Byers, P.H., Ward, P.H., Kellermeyer, R.W., Naff, G.B.: Complement as a mediator of inflammation in acute gouty arthritis. II. Biological activities generated from complement by the interaction of serum complement and sodium urate crystals. J. Lab. clin. Med. 81, 761–769 (1973)
Chang, Y., Gralla, E.J.: Suppression of urate crystal induced joint inflammation by heterologous antipolymorphonuclear leukocyte serum. Arthr. Rheum. 11, 145–150 (1968)
Charache, P., MacLeod, C.M., White, P.: Effects of silicate polymers on erythrocytes in the presence and absence of complement. J. gen. Physiol. 45, 1117–1143 (1962)
Denko, C.W.: Phlogistic action of prostaglandins in urate crystal inflammation. J. Rheum. 1, 24 (abs.) (1974)
Ertel, N.H., Wallace, S.L.: Measurement of colchicine in urine and peripheral blood leukocytes. Clin. Res. 19, 348 (1971)
Faires, J.S., McCarty, D.J.: Acute arthritis in man and dog after intrasynovial injection of sodium urate crystals. Lancet 1962II, 682–685
Freudweiler, M.: Studies on the nature of gouty tophi. Dtsch. Arch. klin. Med. 63, 266–335 (1899)
Freudweiler, M.: Experimental investigations into the origin of gouty tophi. Dtsch. Arch. klin. Med. 69, 155–205 (1901)
Garrod, A.B.: A treatise on Gout and Rheumatic Gout (Rheumatoid Arthritis) 3rd ed. London: Longmans, Green and Co. 1876
His, W., Jr.: Fate and effects of the acid uric acid sodium in the abdominal and joint cavities of the rabbit. Dtsch. Arch. klin. Med. 67, 81–108 (1900)
Hoffstein, S., Weissmann, G.: Mechanisms of lysosomal enzyme release from leukocytes. IV. Interaction of monosodium urate crystals with dogfish and human leukocytes. Arthr. Rheum. 18, 153–166 (1975)
Hollingsworth, J.W., Atkins, E.: Synovial inflammatory response to bacterial endotoxin. Yale J. Biol. Med. 38, 241–256 (1965)
Kellermeyer, R.W.: The inflammatory process in acute gouty arthritis. III. Vascular permeability enhancing activity in normal human synovial fluid; induction by Hageman factor activators; and inhibition by Hageman factor antiserum. J. Lab. clin. Med. 70, 372–383 (1967)
Kellermeyer, R.W., Breckenridge, R.T.: The inflammatory process in acute gouty arthritis. I. Activation of Hageman factor by sodium urate crystals. J. Lab. clin. Med. 65, 307–315 (1965)
Kellermeyer, R.W., Breckenridge, R.T.: The inflammatory process in acute gouty arthritis. II. The presence of Hageman factor and plasma thromboplastin antecedent in synovial fluid. J. Lab. clin. Med. 67, 455–460 (1966)
Kozin, F., McCarty, D.J.: Protein adsorption to monosodium urate, calcium pyrophosphate dihydrate and silica crystals: relationship to the pathogenesis of crystal-induced inflammation. In: McCarty, D.J. (Ed.): Symposium on Pseudogout and Pyrophosphate Metabolism. Arthr. Rheum. Suppl. 19, 433–438 (1976)
Kozin, F., McCarty, D.J.: Unpublished data
Lussier, A., de Medicis, R.: Mechanism of phagolysosome membranolysis by urate crystals. J. Rheum. 1 (suppl.), 23 (abs.) (1974)
Malawista, S.E., Seegmiller, J.E.: The effect of pretreatment with colchicine on the inflammatory response to microcrystalline urate. Ann. intern. Med. 62, 648–657 (1965)
Mandel, N.S.: The crystal structure of calcium pyrophosphate dihydrate. Acta crystallogr. B31, 1730–1734 (1975)
Mandel, N.S.: The structural basis of crystal-induced membranolysis. In: Symposium on Pseudogout and Pyrophosphate Metabolism. McCarty, D.J. (ed.). Arthr. Rheum. Suppl. 19, 439–445 (1976)
Mandel, N.S., Mandel, G.S.: Monosodium urate monohydrate: the gout culprit. J. Amer. chem. Soc. 98, 2319–2323 (1976)
McCarty, D.J.: Phagocytosis of urate crystals in gouty synovial fluid. Amer. J. med. Sci. 243, 288–295 (1962)
McCarty, D.J.: A historical note: Leeuwenhoek’s description of crystals from a gouty tophus. Arthr. Rheum. 13, 414–418 (1970a)
McCarty, D.J.: Pathogenesis and treatment of the acute attack of gout. Clin. Orthop. 71, 28–39 (1970b)
McCarty, D.J.: Urate crystal phagocytosis by polymorphonuclear leukocytes and the effects of colchicine. In: Williams, R.C., Fudenberg, H.H. (Eds.): Phagocytic Mechanisms in Health and Disease. Intercontinental Medical Book Corporation, pp. 107–121. New York-London: Grune and Stratton 1972a
McCarty, D.J.: Pseudogout; articular Chondrocalcinosis. Calcium pyrophosphate crystal deposition disease. In: Hollander, J.L., McCarty, D.J. (Eds.): Arthritis and Allied Conditions, 8th Ed., pp. 1140–1159. Philadelphia: Lea and Febiger 1972b
McCarty, D.J., Gatter, R.A., Brill, J.M., Hogan, J.M.: Crystal deposition diseases. Sodium urate (gout) and calcium pyrophosphate (Chondrocalcinosis, pseudogout). J. Amer. med. Ass. 193, 129–132 (1965)
McCarty, D.J., Hogan, J.M.: Inflammatory reaction after intrasynovial injection of microcrystalline adrenocorticosteroid esters. Arthr. Rheum. 7, 359–367 (1964)
McCarty, D.J., Hollander, J. L.: Identification of urate crystals in gouty synovial fluid. Ann. intern. Med. 54, 452–460 (1961)
McCarty, D.J., Kohn, N.N., Faires, J.S.: The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: The “pseudogout syndrome.” I. Clinical aspects. Ann. intern. Med. 56, 711–737 (1962)
McCarty, D.J., Phelps, P., Pyenson, J.: Crystal induced inflammation in canine joints I. An experimental model with quantification of the host response. J. exp. Med. 124, 99–114 (1966)
Melmon, K.L., Webster, M.E., Goldfinger, S.E., Seegmiller, J.E.: The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies. Arthr. Rheum. 10, 13–20 (1967)
Naff, G.B., Byers, P.H.: Complement as a mediator of inflammation in gout I. Studies on the reaction between human serum complement and sodium urate crystals. J. Lab. clin. Med. 81, 747–760 (1973)
Nash, T., Allison, A.C., Harington, J.S.: Physicochemical properties of silica in relation to its toxicity. Nature (Lond.) 207, 874 (1965)
Phelps, P.: Polymorphonuclear leukocyte motility in vitro. IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals. Arthr. Rheum. 13, 1–9 (1970)
Phelps, P., McCarty, D.J.: Unpublished data
Phelps, P., McCarty, D.J.: Crystal-induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes. J. exp. Med. 124, 115–126 (1966)
Phelps, P., McCarty, D.J.: Suppressive effects of indomethacin on crystal-induced inflammation in canine joints and on neutrophilic motility in vitro. J. Pharmacol. exp. Ther. 158, 546–553 (1967)
Phelps, P., McCarty, D.J.: Crystal induced arthritis. Postgrad. Med. 45, 87–94 (1969a)
Phelps, P., McCarty, D.J.: Animal techniques for evaluating anti-inflammatory agents. In: Siegler, P., Mover, J.H. (Eds.): Animal and Clinical Pharmacologic Techniques in Drug Evaluation, Vol.II, pp.742–747. Chicago: Yearbook Publishers 1969b
Phelps, P., Prockop, D.J., McCarty, D.J.: Crystal induced inflammation in canine joints. III. Evidence against bradykinin as a mediator of inflammation. J. Lab. clin. Med. 68, 433–444 (1966)
Phelps, P., Steele, A.D., McCarty, D.J.: Significance of Xenon-133 clearance rate from canine and human joints. Arthr. Rheum. 15, 360–370 (1972)
Riddle, J.M., Bluhm, G.B., Barnhart, M.L.: Ultrastructural study of leukocytes and urates in gouty arthritis. Ann. rheum. Dis. 26, 389–401 (1967)
Riehl, G.: Zur Anatomie der Gicht. Wien. klin. Wschr. 10, 761 (1897)
Scheele, C.W.: Analysis of the calculus vesicae, 1776. In: The Chemical Essays of Charles William Scheele, p. 199. Translated from the transaction of the Academy of Sciences of Stockholm. London: J. Murray 1787
Schumacher, H. R.: The synovitis of pseudogout: electron microscopic observations. Arthr. Rheum. 11, 426–435 (1968)
Schumacher, H.R.: Phagocytosis of calcium pyrophosphate crystals by polymorphonuclear leukocytes: sequential electron microscopic observations. Arthr. Rheum. 15, 453 (abs.) (1972)
Schumacher, H.R., Phelps, P.: Sequential changes in human polymorphonuclear leukocytes after urate crystal phagocytosis: an electron microscopic study. Arthr. Rheum. 14, 513–526 (1971)
Seegmiller, J.E., Howell, R.R., Malawista, S.E.: The inflammatory reaction to sodium urate. J. Amer. med. Ass. 180, 469–475 (1962)
Smythe, C.J.: Diagnosis and treatment of gout. In: Hollander, J.L., McCarty, D.J. (Eds.): Arthritis and Allied Conditions, pp. 1112–1139. Philadelphia: Lea and Febiger 1972
Spilberg, I.: Studies on the mechanism of inflammation induced by calcium pyrophosphate crystals. J. Lab. clin. Med. 82, 86–91 (1973)
Spilberg, I.: Urate crystal arthritis in animals lacking Hageman factor. Arthr. Rheum. 17, 143–148 (1974)
Spilberg, I., Mandell, B., Wochner, R.D.: Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity. J. Lab. clin. Med. 83, 56–63 (1974)
Spilberg, I., Osterland, C.K.: Anti-inflammatory effect of the trypsin-kallikrein inhibitor in acute arthritis induced by urate crystals in rabbits. J. Lab. clin. Med. 76, 472–479 (1970)
Steele, A.D., McCarty, D.J.: An experimental model of inflammation in man. Arthr. Rheum. 9, 430–442 (1966)
Steele, A.D., McCarty, D.J.: Suppressive effects of indoxole in crystal-induced synovitis in man. Ann. rheum. Dis. 26, 39–42 (1967)
Tse, R.L., Phelps, P.: Polymorphonuclear leukocyte motility in vitro. V. Release of chemotactic activity following phagocytosis of calcium pyrophosphate crystals, diamond dust, and urate crystals. J. Lab. clin. Med. 76, 403–415 (1970)
Van Arman, C.G., Carlson, R.P., Kling, P.J., Allen, D.J., Bondi, J.V.: Experimental gouty synovitis caused by bacterial endotoxin adsorbed onto urate crystals. Arthr. Rheum. 17, 439–450 (1974)
Wallace, S.L., Omokoku, B., Ertel, N.H.: Colchicine plasma levels—Implications as to pharmacology and mechanisms of action. Amer. J. Med. 48, 443–448 (1970)
Wallingford, W.R., McCarty, D.J.: Differential membranolytic effects of microcrystalline sodium urate and calcium pyrophosphate dihydrate. J. exp. Med. 133, 100–112 (1971)
Wallingford, W.R., Trend, B.: Phagolysosome rupture after monosodium urate (MSU) but not calcium pyrophosphate dihydrate (CPPD) phagocytosis in vitro. Arthr. Rheum. 14, 420 (abs.) (1971)
Weissmann, G., Rita, G.: Molecular basis of gouty inflammation: interaction of monosodium urate crystals with lysosomes and liposomes. Nature (New Biol.) 240, 167–172 (1972)
Weissmann, G., Zurier, R.B., Spieler, P.G., Goldstein, I.M.: Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particle. J. exp. Med. 134, Suppl., 149s + (1971)
Zigmond, S.H., Hirsch, J.G.: Leukocyte locomotion and Chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J. exp. Med. 137, 387–410 (1973)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
McCarty, D.J. (1979). Short-Term Drug Control of Crystal-Induced Inflammation. In: Vane, J.R., Ferreira, S.H. (eds) Anti-Inflammatory Drugs. Handbook of Experimental Pharmacology, vol 50 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66891-3_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-66891-3_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66893-7
Online ISBN: 978-3-642-66891-3
eBook Packages: Springer Book Archive